(Q35449950)

8 August 2017

title

Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies (English)

1 reference

8 August 2017

5

van der Meché FG

1 reference

8 August 2017

Martina IS

1

1 reference

8 August 2017

van Doorn PA

series ordinal

2

1 reference

8 August 2017

Schmitz PI

series ordinal

3

1 reference

8 August 2017

Meulstee J

series ordinal

4

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

8 August 2017

published in

1 reference

8 August 2017

volume

66

1 reference

8 August 2017

issue

2

1 reference

8 August 2017

page(s)

197-201

1 reference

A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736225

Multifocal motor neuropathy: response to human immune globulin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736225

Interferon-alpha may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736225

Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736225

The interferons: biological effects, mechanisms of action, and use in multiple sclerosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736225

Interobserver agreement for the assessment of handicap in stroke patients.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736225

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736225

Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736225

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736225

Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome

26 September 2018

1 reference

12 December 2020

Multifocal demyelinating motor neuropathy: pathologic evidence of 'inflammatory demyelinating polyradiculoneuropathy'

1 reference

12 December 2020

Biopsy findings link multifocal motor neuropathy to chronic inflammatory demyelinating polyneuropathy

1 reference

12 December 2020

S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

1 reference

12 December 2020

Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-alpha 2a

1 reference

12 December 2020

Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy

1 reference

12 December 2020

A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside

1 reference

12 December 2020

Mobility after stroke: reliability of measures of impairment and disability

1 reference

12 December 2020

Immunosuppressive treatment in multifocal motor neuropathy

1 reference

12 December 2020

Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

12 December 2020

A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.66.2.197

1 reference

8 August 2017

1 reference

8 August 2017

1 reference